High prevalence of autoantibodies to hLAMP-2 in anti-neutrophil cytoplasmic antibody-associated vasculitis

Journal of the American Society of Nephrology

Volumn 23, Issue 3, 2012, Pages 556-566

  Kain, Renate ^a   Tadema, Henko ^b   McKinney, Eoin F ^c   Benharkou, Alexandra ^a   Brandes, Ricarda ^a   Peschel, Andrea ^a   Hubert, Virginie ^a   Feenstra, Tjerk ^a   Sengölge, Gürkan ^a   Stegeman, Coen ^b   Heeringa, Peter ^b   Lyons, Paul A ^c   Smith, Kenneth G C ^c   Kallenberg, Cees ^b   Rees, Andrew J ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; COMPLEMENTARY DNA; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 2; MYELOBLASTIN; MYELOPEROXIDASE;

ANCA ASSOCIATED VASCULITIS; ANIMAL CELL; ARTICLE; AUSTRIA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HUMAN; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; NETHERLANDS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENT DISEASE; SENSITIVITY ANALYSIS; UNITED KINGDOM; WESTERN BLOTTING;

EID: 84863393655     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2011090920     Document Type: Article

References (28)

1. Jennette JC, Falk RJ: Small-vessel vasculitis. N Engl J Med 337: 1512-1523, 1997 (Pubitemid 27495778)
2. Morgan MD, Harper L, Williams J, Savage C: Anti-neutrophil cytoplasm-associated glomerulonephritis. J Am Soc Nephrol 17: 1224-1234, 2006 (Pubitemid 43673402)
3. Flossmann O, Berden A, de Groot K, Hagen C, Harper L, Heijl C, Höglund P, Jayne D, Luqmani R, Mahr A, Mukhtyar C, Pusey C, Rasmussen N, Stegeman C, Walsh M, Westman K European Vasculitis Study Group: Long-term patient survival in ANCA-associated vasculitis. Ann Rheum Dis 70: 488-494, 2011
4. Jennette JC, Xiao H, Falk RJ: Pathogenesis of vascular inflammation by anti-neutrophil cytoplasmic antibodies. J Am Soc Nephrol 17: 1235-1242, 2006 (Pubitemid 43673403)
5. Xiao H, Heeringa P, Hu P, Liu Z, Zhao M, Aratani Y, Maeda N, Falk RJ, Jennette JC: Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. J Clin Invest 110: 955-963, 2002
6. Heeringa P, Little MA: In vivo approaches to investigate ANCA associated vasculitis: Lessonsandlimitations. ArthritisRes Ther 13: 204, 2011
7. van der Geld YM, Hellmark T, Selga D, Heeringa P, Huitema MG, Limburg PC, Kallenberg CG: Rats and mice immunised with chimeric human/mouse proteinase 3 produce autoantibodies to mouse Pr3 and rat granulocytes. Ann Rheum Dis 66: 1679-1682, 2007 (Pubitemid 350205462)
8. Ruth AJ, Kitching AR, Kwan RY, Odobasic D, Ooi JD, Timoshanko JR, Hickey MJ, Holdsworth SR: Anti-neutrophil cytoplasmic antibodies and effector CD4+ cells play nonredundant roles in anti-myeloperoxidase crescentic glomerulonephritis. J Am Soc Nephrol 17: 1940-1949, 2006 (Pubitemid 44036178)
9. Huugen D, Xiao H, van Esch A, Falk RJ, Peutz-Kootstra CJ, Buurman WA, Tervaert JW, Jennette JC, Heeringa P: Aggravation of anti-myeloperoxidase antibody-induced glomerulonephritis by bacterial lipopolysaccharide: Role of tumor necrosis factor-alpha. Am J Pathol 167: 47-58, 2005 (Pubitemid 40884769)
10. De'Oliviera J, Gaskin G, Dash A, Rees AJ, Pusey CD: Relationship between disease activity and anti-neutrophil cytoplasmic antibody concentration in long-term management of systemic vasculitis. Am J Kidney Dis 25: 380-389, 1995
11. Schmitt WH, van der Woude FJ: Clinical applications of antineutrophil cytoplasmic antibody testing. Curr Opin Rheumatol 16: 9-17, 2004 (Pubitemid 38041393)
12. Kallenberg CG, Stegeman CA, Bootsma H, Bijl M, Limburg PC: Quantitation of autoantibodies in systemic autoimmune diseases: Clinically useful? Lupus 15: 397-402, 2006 (Pubitemid 44147083)
13. Kain R, Matsui M, Exner M, Binder S, Schaffner G, Sommer EM, Kerjaschki D: A novel class of autoantigens of anti-neutrophil cytoplasmic antibodies in necrotizing and crescentic glomerulonephritis: The lysosomalmembrane glycoprotein h-lamp-2 in neutrophil granulocytes and a related membrane protein in glomerular endothelial cells. J Exp Med 181: 585-597, 1995
14. Kain R, Exner M, Brandes R, Ziebermayr R, Cunningham D, Alderson CA, Davidovits A, Raab I, Jahn R, Ashour O, Spitzauer S, Sunder-Plassmann G, Fukuda M, Klemm P, Rees AJ, Kerjaschki D: Molecular mimicry in pauciimmune focal necrotizing glomerulonephritis. Nat Med 14: 1088-1096, 2008
15. Carlsson SR, Roth J, Piller F, Fukuda M: Isolation and characterization of human lysosomal membrane glycoproteins, h-lamp-1 and h-lamp-2. Major sialoglycoproteins carrying polylactosaminoglycan. J Biol Chem 263: 18911-18919, 1988 (Pubitemid 19016351)
16. Gough NR, Fambrough DM: Different steady state subcellular distributions of the three splice variants of lysosome-associated membrane protein LAMP-2 are determined largely by the COOH-terminal amino acid residue. J Cell Biol 137: 1161-1169, 1997 (Pubitemid 27251050)
17. Beck LH Jr, Bonegio RG, Lambeau G, Beck DM, Powell DW, Cummins TD, Klein JB, Salant DJ: M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl JMed 361: 11-21, 2009
18. Roth AJ, Brown MC, Smith RN, Badhwar AK, Parente O, Chung HC, Bunch DO, McGregor JG, Hogan SL, Hu Y, Yang JJ, Berg EA, Niles J, Jennette JC, Preston GA, Falk RJ: Anti-LAMP-2 antibodies are not prevalent in patients with antineutrophil cytoplasmic autoantibody glomerulonephritis [published online ahead of print]. J Am Soc Nephrol doi:10.1681/ASN.2011030273
19. Remaley AT, Ugorski M, Wu N, Litzky L, Burger SR, Moore JS, Fukuda M, Spitalnik SL: Expression of human glycophorin A in wild type and glycosylation-deficient Chinese hamster ovary cells. Role of N- and O-linked glycosylation in cell surface expression. J Biol Chem 266: 24176-24183, 1991
20. StoneJH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, Kallenberg CG, St Clair EW, Turkiewicz A, Tchao NK, Webber L, Ding L, Sejismundo LP, Mieras K, Weitzenkamp D, Ikle D, Seyfert-Margolis V, Mueller M, Brunetta P, Allen NB, Fervenza FC, Geetha D, Keogh KA, Kissin EY, Monach PA, Peikert T, Stegeman C, Ytterberg SR, Specks U RAVE-ITN Research Group: Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med 363: 221-232, 2010
21. Schwan WR, Seifert HS, Duncan JL: Growth conditions mediate differential transcription of fimgenes involved in phase variation of type 1 pili. J Bacteriol 174: 2367-2375, 1992
22. Rothman JE, Wieland FT: Protein sorting by transport vesicles. Science 272: 227-234, 1996
23. Arbuckle MR, McClain MT, Rubertone MV, Scofield RH, Dennis GJ, James JA, Harley JB: Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349: 1526-1533, 2003 (Pubitemid 37255038)
24. Isenberg DA, Manson JJ, Ehrenstein MR, Rahman A: Fifty years of antids DNA antibodies: Are we approaching journey's end? Rheumatology (Oxford) 46: 1052-1056, 2007 (Pubitemid 47050602)
25. Keogh KA, Specks U: Churg-Strauss syndrome: Clinical presentation, antineutrophil cytoplasmic antibodies, and leukotriene receptor antagonists. Am J Med 115: 284-290, 2003 (Pubitemid 37088190)
26. Kobayashi T, Vischer UM, Rosnoblet C, Lebrand C, Lindsay M, Parton RG, Kruithof EK, Gruenberg J: The tetraspanin CD63/lamp3 cycles between endocytic and secretory compartments in human endothelial cells. Mol Biol Cell 11: 1829-1843, 2000 (Pubitemid 30307916)
27. Janvier K, Bonifacino JS: Role of the endocyticmachinery in the sorting of lysosome-associated membrane proteins. Mol Biol Cell 16: 4231-4242, 2005 (Pubitemid 41262892)
28. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CGM, McCluskey RT, Sinico RA, Rees AJ, van Es LA, Waldherr R, Wiik A: Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 37: 187-192, 1994 (Pubitemid 24065492)